EpiVax, Inc.

EpiVax, Inc. is a biotechnology company based in Providence, Rhode Island, founded in 1998. The company specializes in computational immunology, vaccine design, immunotherapies, and immunogenicity risk assessment for biologics. Co-founded by Dr. Annie S. De Groot and Bill Martin, EpiVax focuses on addressing infectious diseases, autoimmunity, cancer, and biotherapeutic de-risking, operating under the motto "Science Without Fear."

EpiVax has developed several proprietary tools, including EpiMatrix for T-cell epitope identification and Ancer® for personalized cancer vaccines. The company offers services such as immunogenicity risk assessment, vaccine and immunotherapy design, and consulting for preclinical development. EpiVax collaborates with a range of clients, from startups to major pharmaceutical companies, and partners with academic institutions and regulatory agencies. Their commitment to community health is evident through initiatives like VaxGivesBack, which has provided over 17,000 COVID vaccines to uninsured residents in Providence.